Agalsidase Beta: A Review of its Use in the Management of Fabry Disease

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.3, 2007-01, pp. : 435-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methoxy Polyethylene Glycol-Epoetin Beta: A Review of its Use in the Management of Anaemia Associated with Chronic Kidney Disease

By Curran Monique P. McCormack Paul L.

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1139-1156

Adis International

Access to resources Recommend Favorite

Agalsidase alfa – a preparation for enzyme replacement therapy in Anderson–Fabry disease

By Beck Michael

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 851-858

Informa Healthcare

Access to resources Recommend Favorite

Ropinirole: A Review of its Use in the Management of Parkinson's Disease

By Matheson A.J. Spencer C.M.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 115-137

Adis International

Access to resources Recommend Favorite

Tolcapone: A Review of its Use in the Management of Parkinson's Disease

By Gillian M. Keating Katherine A. Lyseng-Williamson

CNS Drugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 165-184

Adis International

Access to resources Recommend Favorite

Rasagiline: A Review of its Use in the Management of Parkinson's Disease

By Oldfield Vicki Keating Gillian M. Perry Caroline M.

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1725-1747

Adis International

Access to resources Recommend Favorite